ASHLEY AMEDEE: Open Payments
NPI 1962719690 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,635 in 44 payments from 20 companies in 2025. Trend: 2023 $1,778 · 2024 $2,216 · 2025 $1,635
Food & beverage: $1,635
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $203 |
| Dexcom, Inc. | 3 | $194 |
| Abbott Laboratories | 6 | $172 |
| Enterra Medical, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 1 | $123 |
| KYOWA KIRIN, INC. | 1 | $118 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Novo Nordisk Inc | 5 | $87 |
| Lilly USA, LLC | 5 | $83 |
| PFIZER INC. | 4 | $80 |
Products named: Kerecis SurgiClose, FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), REZDIFFRA, Ozempic, AREXVY, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across LA — which companies pay providers there.
